Price movement over the last 24 hours
AdaptHealth Corp vs Eaton Corporation plc — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Eaton Corporation plc trades at $398.03 (market cap $153.64B). The key difference: Eaton Corporation plc is far larger — about 111.3× AdaptHealth Corp's market cap, and Eaton Corporation plc pays a 1.11% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | ETN | |
|---|---|---|
Market Cap | $1.38B | $153.64B |
Sector | Health | Technology |
52-Week High | $13.38 | $435.78 |
52-Week Low | $8.68 | $315.82 |
Enterprise Value | $3.33B | $174.72B |
Dividend Yield | — | 1.11% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Eaton (ETN) trades at $413.42, up 3.74% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 20.87% ROE and 13.99% net margin, though valuation ratios like a 40.45 P/E are elevated. Recent news highlights sustainability investments and AI infrastructure opportunities, while analyst consensus remains strongly positive with a $449.50 price target.
Outlook is supported by earnings momentum and sector tailwinds, but high valuation and competitive pressures pose risks. The absence of sell ratings and institutional bullishness suggest upside potential, though investors should weigh growth against premium multiples in a volatile market environment.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →